Seaport Therapeutics, Inc. (SPTX)
NASDAQ: SPTX · Real-Time Price · USD
23.71
-0.09 (-0.38%)
At close: Aug 13, 2026, 4:00 PM EDT
23.66
-0.05 (-0.21%)
After-hours: Aug 13, 2026, 7:34 PM EDT
Seaport Therapeutics Earnings Call Transcripts
Fiscal Year 2026
-
The company presented its neuropsychiatry-focused pipeline, highlighting the Glyph platform's ability to improve oral bioavailability and safety of known drugs. Key milestones include phase II-B and driving study data for GlyphAllo in 2026–2027 and phase II studies for GlyphAgo in 2028, with funding secured into 2029.